Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

被引：0
|
作者：
Wichard Vogel
Hans-Georg Kopp
Lothar Kanz
Hermann Einsele
机构：
[1] University of Tübingen,Department of Internal Medicine II, Division of Hematology, Oncology, Immunology and Rheumatology
来源：
Journal of Cancer Research and Clinical Oncology | 2005年 / 131卷
关键词：
Multiple myeloma; Peripheral autologous transplantation; Graft contamination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：214 / 218
页数：4
相关论文
共 50 条
  • [21] Improved survival with salvage autologous stem-cell transplantation in myeloma
    Holstein, Sarah A.
    McCarthy, Philip L.
    LANCET HAEMATOLOGY, 2016, 3 (07): : E306 - E307
  • [22] Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma
    Menzel, Helge
    Hinmueller, Katarzyna
    Kolb, Hans-Jochem
    Schuster, Tibor
    Hoellein, Alexander
    Peschel, Christian
    Dechow, Tobias
    Keller, Ulrich
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 81 - 88
  • [23] Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation
    Fenk, Roland
    Neubauer, Florian
    Bruns, Ingmar
    Schroeder, Thomas
    Germing, Ulrich
    Haas, Rainer
    Kobbe, Guido
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) : 683 - 686
  • [24] BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    ALEGRE, A
    LAMANA, M
    ARRANZ, R
    FERNANDEZVILLALTA, MJ
    TOMAS, JF
    FIGUERA, A
    CAMARA, R
    STEEGMAN, JL
    CASADO, F
    REQUENA, MJ
    PLANAS, JL
    VAZQUEZ, L
    GRANDA, A
    FERNANDEZRANADA, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 380 - 386
  • [25] Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
    Roerden, Malte
    Wirths, Stefan
    Soekler, Martin
    Bethge, Wolfgang A.
    Vogel, Wichard
    Walz, Juliane S.
    CANCERS, 2021, 13 (11)
  • [26] Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
    Kazmi, Syed M.
    Nusrat, Maliha
    Gunaydin, Hilal
    Cornelison, Amanda M.
    Shah, Nina
    Kebriaei, Partow
    Nieto, Yago
    Parmar, Simrit
    Popat, Uday R.
    Oran, Betul
    Shah, Jatin J.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (11): : 687 - 693
  • [27] Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantation
    Facon, Thierry
    Darre, Stephane
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 737 - 746
  • [28] HIGH-DOSE THERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL INVOLVING 167 PATIENTS
    FERMAND, JP
    RAVAUD, P
    CHEVRET, S
    LEBLOND, V
    DIVINE, M
    DREYFUS, F
    BELANGER, C
    TROUSSARD, X
    MARIETTE, X
    BROUET, JC
    STEM CELLS, 1995, 13 : 156 - 159
  • [29] Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
    Bensinger, William I.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 783 - 795
  • [30] REFRACTORY AND RELAPSING MULTIPLE-MYELOMA TREATED BY BLOOD STEM-CELL TRANSPLANTATION
    GERTZ, MA
    PINEDA, AA
    CHEN, MG
    LETENDRE, L
    GREIPP, PR
    SOLBERG, JP
    WITZIG, TE
    GARTON, JP
    INWARDS, DJ
    LITZOW, MR
    TEFFERI, A
    KYLE, RA
    NOEL, P
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1995, 309 (03): : 152 - 161
12345